These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26299768)

  • 61. SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma.
    Zhao Z; Ma J; Wu K; Chen L; Yu J; Hu W; Zhang K
    Clin Transl Oncol; 2016 Sep; 18(9):878-83. PubMed ID: 26563145
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
    Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
    Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3.
    Zeng B; Li Z; Chen R; Guo N; Zhou J; Zhou Q; Lin Q; Cheng D; Liao Q; Zheng L; Gong Y
    FEBS Lett; 2012 Sep; 586(19):3271-8. PubMed ID: 22819820
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis.
    Huang Q; Liu L; Liu CH; You H; Shao F; Xie F; Lin XS; Hu SY; Zhang CH
    Asian Pac J Cancer Prev; 2013; 14(2):829-34. PubMed ID: 23621247
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

  • 66. S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway.
    Zheng S; Shen H; Jia Q; Jing C; Lin J; Zhang M; Zhang X; Zhang B; Liu Y
    Future Oncol; 2017 Oct; 13(23):2053-2063. PubMed ID: 28984474
    [TBL] [Abstract][Full Text] [Related]  

  • 67. miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.
    Ehrlich L; Hall C; Venter J; Dostal D; Bernuzzi F; Invernizzi P; Meng F; Trzeciakowski JP; Zhou T; Standeford H; Alpini G; Lairmore TC; Glaser S
    Am J Pathol; 2017 Mar; 187(3):570-580. PubMed ID: 28087162
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Downregulation of ROS-FIG inhibits cell proliferation, colony‑formation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells.
    Deng G; Hu C; Zhu L; Huang F; Huang W; Xu H; Nie W
    Int J Mol Med; 2014 Sep; 34(3):661-8. PubMed ID: 24968753
    [TBL] [Abstract][Full Text] [Related]  

  • 69. TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF-κB pathway-mediated inflammatory responses.
    Liu B; Yan S; Jia Y; Ma J; Wu S; Xu Y; Shang M; Mao A
    FEBS J; 2016 Oct; 283(20):3839-3850. PubMed ID: 27616304
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Decreased roundabout 1 expression promotes development of intrahepatic cholangiocarcinoma.
    Mano Y; Aishima S; Fukuhara T; Tanaka Y; Kubo Y; Motomura T; Toshima T; Iguchi T; Shirabe K; Maehara Y; Oda Y
    Hum Pathol; 2013 Nov; 44(11):2419-26. PubMed ID: 23953227
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
    Dong Z; Liao B; Shen W; Sui C; Yang J
    Dig Dis Sci; 2020 Feb; 65(2):480-488. PubMed ID: 31410753
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Blockage of CXCR2 suppresses tumor growth of intrahepatic cholangiocellular carcinoma.
    Sueoka H; Hirano T; Uda Y; Iimuro Y; Yamanaka J; Fujimoto J
    Surgery; 2014 Apr; 155(4):640-9. PubMed ID: 24582495
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fatty acid-binding protein 5 promotes cell proliferation and invasion in human intrahepatic cholangiocarcinoma.
    Jeong CY; Hah YS; Cho BI; Lee SM; Joo YT; Jung EJ; Jeong SH; Lee YJ; Choi SK; Ha WS; Park ST; Hong SC
    Oncol Rep; 2012 Oct; 28(4):1283-92. PubMed ID: 22825302
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.
    Chi BJ; Du CL; Fu YF; Zhang YN; Wang RW
    Int J Clin Exp Pathol; 2015; 8(10):12533-40. PubMed ID: 26722441
    [TBL] [Abstract][Full Text] [Related]  

  • 75. LncRNA PVT1 regulates VEGFC through inhibiting miR-128 in bladder cancer cells.
    Yu C; Longfei L; Long W; Feng Z; Chen J; Chao L; Peihua L; Xiongbing Z; Hequn C
    J Cell Physiol; 2019 Feb; 234(2):1346-1353. PubMed ID: 30076714
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway.
    Zhang H; Dong X; Ding X; Liu G; Yang F; Song Q; Sun H; Chen G; Li S; Li Y; Wang M; Guo T; Zhang Z; Li B; Yang L
    J Transl Med; 2023 Dec; 21(1):900. PubMed ID: 38082327
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Depletion of STYK1 inhibits intrahepatic cholangiocarcinoma development both in vitro and in vivo.
    Chen MY; Zhang H; Jiang JX; Sun CY; Yu C; Tian S
    Tumour Biol; 2016 Oct; 37(10):14173-14181. PubMed ID: 27542675
    [TBL] [Abstract][Full Text] [Related]  

  • 78. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma.
    Ohashi T; Eguchi H; Kawamoto K; Konno M; Asai A; Colvin H; Ueda Y; Takaoka H; Iwagami Y; Yamada D; Asaoka T; Noda T; Wada H; Gotoh K; Kobayashi S; Koseki J; Satoh T; Ogawa K; Doki Y; Mori M; Ishii H
    Oncol Rep; 2018 Mar; 39(3):1276-1282. PubMed ID: 29286150
    [TBL] [Abstract][Full Text] [Related]  

  • 80. WAVE3 Induces EMT and Promotes Migration and Invasion in Intrahepatic Cholangiocarcinoma.
    Zhu Z; Chen W; Yin X; Lai J; Wang Q; Liang L; Wang W; Wang A; Zheng C
    Dig Dis Sci; 2016 Jul; 61(7):1950-60. PubMed ID: 26971088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.